Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality

  1. Nicolas Ochs, MD;
  2. Reto Auer, MD;
  3. Douglas C. Bauer, MD;
  4. David Nanchen, MD;
  5. Jacobijn Gussekloo, MD, MPH;
  6. Jacques Cornuz, MD, MPH; and
  7. Nicolas Rodondi, MD, MAS
  1. From University of Lausanne, Lausanne, Switzerland; University of California, San Francisco, San Francisco, California; and Leiden University Medical Center, Leiden, the Netherlands.
    1. Figure 1.
      View larger version:
      Figure 1. Study flow diagram.

      TSH = thyroid-stimulating hormone.

    2. Figure 2.
      View larger version:
      Figure 2. Forest plots for subclinical hypothyroidism.

      The diamonds represent relative risks and the horizontal lines represent 95% CIs of the effect of subclinical hypothyroidism. CHD = coronary heart disease; CV = cardiovascular.

    3. Figure 3.
      View larger version:
      Figure 3. Forest plots for subclinical hyperthyroidism.

      The diamonds represent relative risks and the horizontal lines represent 95% CIs of the effect of subclinical hyperthyroidism. CHD = coronary heart disease; CV = cardiovascular.

    Responses to this article

    • Bed-Side Biophysical-Semeiotic Evaluation of Thyroid Dysfunction in Cardiology.
      • Sergio Stagnaro
      Ann Intern Med published online October 26, 2009
    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med June 3, 2008 vol. 148 no. 11 832-845
    1. AbstractFREE
    2. » Figures
    3. Full Text
    4. Full Text (PDF)
    5. CME Course

    Current Issue

    1. November 3, 2009, 151 (9)
    1. Alert me to current issues